Recce Pharmaceuticals Ltd.ASX: RCE

Patients to be Dosed in Ph 1 IV Clinical Trial of R327

Dec 15, 2021 at 3:44 AM UTC · Issued by Recce Pharmaceuticals Ltd.

Recce Ltd has released a press release.

View Attachment